These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12952231)

  • 21. Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders.
    Zhang Y; Ohyashiki JH; Shimizu N; Ohyashiki K
    Hematology; 2010 Feb; 15(1):43-7. PubMed ID: 20132662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-lymphocyte subsets and Th1/Th2 cytokines in convalescent patients with Epstein-Barr virus-associated aplastic anemia.
    Chen T; Chen Y; Bao W; Lu W
    Hematology; 2020 Dec; 25(1):11-16. PubMed ID: 31842718
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
    Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
    Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
    Cho EY; Kim KH; Kim WS; Yoo KH; Koo HH; Ko YH
    J Korean Med Sci; 2008 Apr; 23(2):185-92. PubMed ID: 18436998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-associated T-cell lymphoproliferative disorder affecting skin and lung in an elderly patient.
    Hoshino T; Tatsuno K; Shimauchi T; Okada S; Ito T; Ono T; Ohshima K; Tokura Y
    J Dermatol; 2014 Sep; 41(9):837-40. PubMed ID: 25109697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
    Okuno Y; Murata T; Sato Y; Muramatsu H; Ito Y; Watanabe T; Okuno T; Murakami N; Yoshida K; Sawada A; Inoue M; Kawa K; Seto M; Ohshima K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Narita Y; Yoshida M; Goshima F; Kawada JI; Nishida T; Kiyoi H; Kato S; Nakamura S; Morishima S; Yoshikawa T; Fujiwara S; Shimizu N; Isobe Y; Noguchi M; Kikuta A; Iwatsuki K; Takahashi Y; Kojima S; Ogawa S; Kimura H
    Nat Microbiol; 2019 Mar; 4(3):404-413. PubMed ID: 30664667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
    Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
    J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.
    Ohga S; Kimura N; Takada H; Nagano M; Ohshima K; Nomura A; Muraoka K; Take H; Yamamori S; Hara T
    Am J Hematol; 1999 May; 61(1):26-33. PubMed ID: 10331508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.
    Morales O; Mrizak D; François V; Mustapha R; Miroux C; Depil S; Decouvelaere AV; Lionne-Huyghe P; Auriault C; de Launoit Y; Pancré V; Delhem N
    Br J Haematol; 2014 Sep; 166(6):875-90. PubMed ID: 25041527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.
    Nakayama T; Hieshima K; Nagakubo D; Sato E; Nakayama M; Kawa K; Yoshie O
    J Virol; 2004 Feb; 78(4):1665-74. PubMed ID: 14747532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBV in T-/NK-Cell Tumorigenesis.
    Kimura H
    Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection.
    Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
    Pathol Int; 1999 Jan; 49(1):9-13. PubMed ID: 10227719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases.
    Hatta K; Morimoto A; Ishii E; Kimura H; Ueda I; Hibi S; Todo S; Sugimoto T; Imashuku S
    Haematologica; 2007 Nov; 92(11):1470-4. PubMed ID: 18024394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.